Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Texas approves first medical license, but program is flawed for patients and docs

Texas approves first medical license, but program is flawed for patients and docsThe Texas Department of Safety recently approved the first of three medical cannabis production licenses allowed under the state Compassionate Use program, passed 2 years ago. But the program is so restrictive, few patients will qualify, and few doctors will likely participate due to occupational risks.

The Compassionate Use program allows medical cannabis only for patients with severe epilepsy. This rules out a vast number of potential patients with other medical conditions. Further, the program requires that doctors actually write prescriptions for patients, which is not required in other states. This exposes them to the risk of prosecution under Federal Law, where cannabis is still illegal. There are only 411 doctors in the state (less than 1%) who qualify to prescribe cannabis in the first place. Many of these may decline, given the risk.

According to Heather Fazio, Texas political director for the Marijuana Policy Project, “The few patients that could be helped by this program are now one step closer to finding relief. However, the extremely limited scope and flawed language may doom the program unless it is revised. Lawmakers need to stop stalling and approve comprehensive improvements when they are back in session in 2019. Seriously ill Texans have waited long enough.”

Earlier this year, Rep. Eddie Lucio III introduced HB 2107, a bill designed to fix the flaws in the existing program. But the bill did not reach the floor for a vote before the session ended.

According to a 2017 poll, the majority of Texans support a medical marihuana program. Both political parties have adopted platforms that call for improving the program.

Source: The Marihuana Policy Project press release, Sept 1, 2017.

Texas approves first medical license, but program is flawed for patients and docs

About Cannin.com: Your Marijuana Stocks Resource

Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now. 

Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?

Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • 108% Backtested since 2012

We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In